image
Processa Pharmaceuticals, Inc. PCSA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.0099
-6.49 %
$ 3.3 M
Market Cap
-0.19
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-11.5 M OPERATING INCOME
58.38%
Growth Rates
1Year 58.38%
3Years 8.87%
5Years -20.42%
7Years -106.70%
10Years -14.49%
-11.1 M NET INCOME
59.45%
Growth Rates
1Year 59.45%
3Years 8.28%
5Years -24.19%
7Years -64.78%
10Years -13.74%
EFFICIENCY
Earnings Waterfall Processa Pharmaceuticals, Inc.
image
Revenue 0
Cost Of Revenue 222
Gross Profit -222
Operating Expenses 11.5 M
Operating Income -11.5 M
Other Expenses -336 K
Net Income -11.1 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010
REVENUE
Revenue 0 0 0 0 0 0 0 5 K 0.1 0.2 0.3 0.2 20 K 0.1
GROSS PROFIT
Cost Of Revenue 222 27.5 12.1 15.1 0.9 0.6 1.86 K 1.38 K 0.1 0.1 0.2 0.1 0 0.1
Gross Profit 222 (27.5) (12.1) (15.1) (0.9) (0.6) 1.86 K 3.62 K 12.5 K 87 K 0.1 58.9 K 20 K 10 K
OPERATING INCOME
Operating Expenses 11.5 20.3 11.6 6.4 3.9 4.5 1.8 76.5 K 1.0 3.0 3.1 2.3 0.8 0.1
Selling, General and Administrative Expenses 5.7 8.8 4.7 3.3 1.6 1.4 0.9 70 K 0.9 2.8 2.8 1.9 0.6 40 K
Research and Development Expenses 5.8 11.5 6.9 3.2 2.3 3.1 0.9 6.56 K 29.2 K 0.2 0.3 0.4 0.2 0.1
Operating Income (11.5) (27.5) (12.1) (15.1) (3.9) (4.5) (1.8) 71.5 K 2.7 (4.2) (3.0) (2.3) (0.8) (0.2)
PRE-TAX INCOME
Interest Income Expense 0 (0.1) 362 0.3 36.7 K 0.2 35.7 K 0.2 0.2 0.4 0.1 0.2 (0.2) 0
Total Other Income 0.3 0.1 0.2 (0.3) 25.1 K (0.1) 53.9 K 1.6 (2.7) (1.5) (0.1) (0.2) (0.2) 0
Pre-Tax Income (11.1) (27.4) (12.0) (15.4) (4.0) (4.7) (1.9) (0.3) (3.0) (4.5) (3.1) (2.4) (0.9) (0.2)
NET INCOME
Tax Provision 0 27.4 (0.5) (1.0) (0.6) (0.9) 18.2 K 1.2 K 100 100 50 181 0 0
Net Income (11.1) (54.8) (11.4) (14.4) (3.4) (3.8) (1.9) (0.3) (3.4) (4.5) (3.1) (2.4) (0.9) (0.2)
EPS 8.48 68 15 38.4 12.2 14.2 8 29.8 298 501 598 677 20.4 3.4